je.st
news
Home
› CeloNova Announces Accelerated IDE Trial Enrollment Completion For Its COBRA PzF Coronary Stent System
CeloNova Announces Accelerated IDE Trial Enrollment Completion For Its COBRA PzF Coronary Stent System
2015-02-20 03:50:57| surfacefinishing News Articles
CeloNova BioSciences, Inc. announced completion of patient enrollment in the global, multi-center IDE trial for its COBRA PzF stent. Completed enrollment was ahead of schedule and supports submission for FDA approval of the novel COBRA PzF stent with its advanced, nano-thin coating of Polyzene-F polymer
Tags: system
trial
completion
ide
Category:Materials
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||